These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5910815)

  • 1. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current problems in the medical treatment of coronary insufficiency].
    Cunescu V; Pîrvu V
    Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the effect of coronary-active substances in long-term tests on sclerosis in experimental animals].
    Reichertz P; Göhring M
    Arch Kreislaufforsch; 1966 Feb; 49(1):14-27. PubMed ID: 5982369
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of coronary circulation disorders with Adenopurine].
    Mahr H
    Munch Med Wochenschr; 1966 Jan; 108(4):205-9. PubMed ID: 6013263
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug treatment of chronic coronary disease].
    Halawa B
    Wiad Lek; 1980 Jan; 33(2):107-11. PubMed ID: 6768197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Options of NO substitution: proven and future methods. A pharmaceutical classic on the upswing].
    MMW Fortschr Med; 2011 Jun; 153(24-25):50-1. PubMed ID: 21717713
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
    MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome].
    Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A
    Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physio-pharmacology of coronary insufficiency. I].
    Campese VM; Marino A
    Clin Ter; 1974 Mar; 69(4):301-20. PubMed ID: 4152441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.